Trials / Completed
CompletedNCT02430623
Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms: Phase I and Phase II Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Urinary Bladder Neoplasms.
Detailed description
By enrolling patients with unresectable Urinary Bladder Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Urinary Bladder Neoplasms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Irreversible electroporation (IRE) | Irreversible Electroportion For Unresectable Urinary Bladder Neoplasms guide with ultrasound or/and CT. |
| DEVICE | NanoKnife |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-12-01
- Completion
- 2021-03-01
- First posted
- 2015-04-30
- Last updated
- 2021-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02430623. Inclusion in this directory is not an endorsement.